| scholarly article | Q13442814 |
| P50 | author | Yan He | Q57274261 |
| P2093 | author name string | Chao You | |
| Qiong Chen | |||
| Shan Wang | |||
| Liang Zhou | |||
| Jia Yin | |||
| Hong-Wei Zhou | |||
| Su-Yue Pan | |||
| Fei-Tong Liu | |||
| Jia-Jia Zhu | |||
| Geng-Hong Xia | |||
| Shuo-Xi Liao | |||
| P2860 | cites work | Enterotypes of the human gut microbiome | Q24489818 |
| Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk | Q24603491 | ||
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis | Q24629045 | ||
| The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome | Q28846212 | ||
| Search and clustering orders of magnitude faster than BLAST | Q29547431 | ||
| A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
| FastTree: computing large minimum evolution trees with profiles instead of a distance matrix | Q29614577 | ||
| Gut microbiota from twins discordant for obesity modulate metabolism in mice | Q29614796 | ||
| PyNAST: a flexible tool for aligning sequences to a template alignment | Q29616628 | ||
| Human oral, gut, and plaque microbiota in patients with atherosclerosis | Q30499024 | ||
| BIPES, a cost-effective high-throughput method for assessing microbial diversity. | Q30500790 | ||
| Phylogenetic relationships of butyrate-producing bacteria from the human gut. | Q33986987 | ||
| Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry | Q34202445 | ||
| Symptomatic atherosclerosis is associated with an altered gut metagenome | Q34315625 | ||
| Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis | Q34625372 | ||
| Comparison of direct boiling method with commercial kits for extracting fecal microbiome DNA by Illumina sequencing of 16S rRNA tags | Q34881440 | ||
| UniFrac: an effective distance metric for microbial community comparison | Q35018645 | ||
| Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease | Q35033613 | ||
| Implementation of the third universal definition of myocardial infarction after coronary artery bypass grafting: a survey study in Western Europe | Q35088124 | ||
| Metagenomic biomarker discovery and explanation | Q35557728 | ||
| The role of the gut microbiota in nonalcoholic fatty liver disease | Q42838234 | ||
| P433 | issue | 11 | |
| P921 | main subject | dysbiosis | Q269334 |
| atherosclerosis | Q12252367 | ||
| P577 | publication date | 2015-11-23 | |
| P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
| P1476 | title | Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack | |
| P478 | volume | 4 |
| Q93009263 | Alterations in gut microbiota of abdominal aortic aneurysm mice |
| Q38667978 | An unexplored brain-gut microbiota axis in stroke |
| Q42678857 | Analysis of intestinal microbial communities of cerebral infarction and ischemia patients based on high throughput sequencing technology and glucose and lipid metabolism |
| Q92929992 | Analysis of microbiota in elderly patients with Acute Cerebral Infarction |
| Q92999660 | Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders? |
| Q46296054 | Association Between Gut Microbiota and Bone Health: Potential Mechanisms and Prospective |
| Q64097026 | Association of moderately elevated trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic insulin resistance |
| Q57784001 | Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice |
| Q89830117 | Baicalin ameliorates neuropathology in repeated cerebral ischemia-reperfusion injury model mice by remodeling the gut microbiota |
| Q46326062 | Brain-Heart Interaction: Cardiac Complications After Stroke |
| Q61453311 | Brain-gut axis after stroke |
| Q35975949 | Can microbiota research change our understanding of neurodegenerative diseases? |
| Q92704716 | Change of intestinal microbiota in cerebral ischemic stroke patients |
| Q36002203 | Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease |
| Q64889811 | Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. |
| Q89820429 | Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke |
| Q99711559 | Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study |
| Q64885760 | Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death. |
| Q90568782 | Elevation of the Gut Microbiota Metabolite Trimethylamine N-Oxide Predicts Stroke Outcome |
| Q37660757 | Enterotype May Drive the Dietary-Associated Cardiometabolic Risk Factors |
| Q91713597 | Fecal Microbiota Transplantation in Neurological Disorders |
| Q41717735 | Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population. |
| Q64917031 | Gut Microbiome and Cardiovascular Diseases. |
| Q64939888 | Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide. |
| Q90445158 | Gut Microbiota and Stroke |
| Q97518183 | Gut Microbiota in Acute Ischemic Stroke: From Pathophysiology to Therapeutic Implications |
| Q91707045 | Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target |
| Q36271749 | Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke |
| Q90310328 | Gut microbiota and cardiovascular disease: opportunities and challenges |
| Q59330596 | Gut microbiota in common elderly diseases affecting activities of daily living |
| Q98174700 | Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis |
| Q61799983 | Higher Risk of Stroke Is Correlated With Increased Opportunistic Pathogen Load and Reduced Levels of Butyrate-Producing Bacteria in the Gut |
| Q33684162 | Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients |
| Q99617610 | Implications of gut microbiome on coronary artery disease |
| Q55380020 | In vivo imaging biomarkers of neuroinflammation in the development and assessment of stroke therapies - towards clinical translation. |
| Q58700763 | Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis |
| Q57512985 | Making Sense of … the Microbiome in Psychiatry |
| Q98174681 | Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients |
| Q50144047 | Microbial modulation of cardiovascular disease |
| Q36069076 | Microbiome-wide association studies link dynamic microbial consortia to disease |
| Q40614228 | Microbiota Dysbiosis Controls the Neuroinflammatory Response after Stroke. |
| Q39203697 | Microbiota, Immune Subversion, and Chronic Inflammation |
| Q90310883 | Overview of Meta-Analyses: The Impact of Dietary Lifestyle on Stroke Risk |
| Q39247325 | Pathogenic mechanisms following ischemic stroke |
| Q91971264 | Persistence of Gut Microbiota Dysbiosis and Chronic Systemic Inflammation After Cerebral Infarction in Cynomolgus Monkeys |
| Q49348632 | Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases |
| Q47135542 | Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study |
| Q92510163 | Re-thinking the Etiological Framework of Neurodegeneration |
| Q47808638 | Recent developments in understanding the role of the gut microbiota in brain health and disease |
| Q46324355 | Relationship between gut microbiota and type 2 diabetic erectile dysfunction in Sprague-Dawley rats |
| Q57111078 | Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies |
| Q64093570 | Stroke Dysbiosis Index (SDI) in Gut Microbiome Are Associated With Brain Injury and Prognosis of Stroke |
| Q92905399 | TMA, A Forgotten Uremic Toxin, but Not TMAO, Is Involved in Cardiovascular Pathology |
| Q96220346 | TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats |
| Q98721399 | TMAO: How gut microbiota contributes to heart failure |
| Q36340545 | Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery |
| Q38821293 | The Cerebrovascular-Chronic Kidney Disease Connection: Perspectives and Mechanisms |
| Q28069455 | The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke |
| Q92353620 | The Gut Microbiota Affects Host Pathophysiology as an Endocrine Organ: A Focus on Cardiovascular Disease |
| Q98196704 | The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients |
| Q91384443 | The gut microbiome in neurological disorders |
| Q30248605 | The intestinal microbiome and surgical disease. |
| Q92735130 | The progress of gut microbiome research related to brain disorders |
| Q57810328 | Trimethylamine -Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function |
| Q92990246 | Trimethylamine N-Oxide Does Not Impact Viability, ROS Production, and Mitochondrial Membrane Potential of Adult Rat Cardiomyocytes |
| Q90147408 | Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis |
| Q28079182 | Trimethylamine N-Oxide: The Good, the Bad and the Unknown |
| Q101121170 | Trimethylamine N-oxide and the reverse cholesterol transport in cardiovascular disease: a cross-sectional study |
| Q64111295 | Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis |
| Q90932695 | What can the gut microbiome teach us about the connections between child physical and mental health? A systematic review |
| Q89799717 | [Gut-heart axis : How gut bacteria influence cardiovascular diseases] |
Search more.